About this Journal Submit a Manuscript Table of Contents
Advances in Pharmacological Sciences
Volume 2014 (2014), Article ID 924706, 6 pages
Research Article

Embryotoxic and Teratogenic Effects of Norfloxacin in Pregnant Female Albino Rats

1Department of Pharmacology, Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh, Qaliobiya 13736, Egypt
2Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt
3Department of Pharmacology, Faculty of Veterinary Medicine, University of Sadat City, Minoufiya 32897, Egypt

Received 14 November 2013; Revised 13 December 2013; Accepted 13 December 2013; Published 3 February 2014

Academic Editor: Berend Olivier

Copyright © 2014 Mohamed Aboubakr et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. O'Rahilly, Human Embryology & Teratology, Wiley-Liss, New York, NY, USA, 3rd edition, 2001.
  2. P. N. Schlegel, T. S. K. Chang, and F. F. Marshall, “Antibiotics: potential hazards to male fertility,” Fertility and Sterility, vol. 55, no. 2, pp. 235–242, 1991. View at Scopus
  3. K. L. Moore, The Developing Human, WB Saunder, Philadelphia, Pa, USA, 4th edition, 1988.
  4. P. J. A. Amwayi and G. E. Otiang'a-Owiti, “Use of biometric embryonic growth parameters as indicator of exposure to a teratogen,” East African Medical Journal, vol. 74, no. 1, pp. 6–11, 1997. View at Scopus
  5. A. Gürbay, C. Garrel, M. Osman, M.-J. Richard, A. Favier, and F. Hincal, “Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E,” Human and Experimental Toxicology, vol. 21, no. 12, pp. 635–641, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Mehlhorn and D. A. Brown, “Safety concerns with fluoroquinolones,” Annals of Pharmacotherapy, vol. 41, no. 11, pp. 1859–1866, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. S. Wolfson and D. C. Hooper, “Fluoroquinolone antimicrobial agents,” Clinical Microbiology Reviews, vol. 2, no. 4, pp. 378–424, 1989. View at Scopus
  8. P. B. Fernandes, “Mode of action, and in vitro and in vivo activities of the fluoroquinolones,” Journal of Clinical Pharmacology, vol. 28, no. 2, pp. 156–168, 1988. View at Scopus
  9. G. L. Hassert, P. J. DeBaecke, J. S. Kulesza, V. M. Traina, D. P. Sinha, and E. Bernal, “Toxicological, pathological, and teratological studies in animals with cephradine,” Antimicrobial Agents and Chemotherapy, vol. 3, no. 6, pp. 682–685, 1973. View at Scopus
  10. D. J. MacIntyre, H.-H. Chang, and M. H. Kaufman, “Teratogenic effects of amniotic sac puncture: a mouse model,” Journal of Anatomy, vol. 186, no. 3, pp. 527–539, 1995. View at Scopus
  11. P. Barcellona, O. Fanelli, and A. Campana, “Teratological study of etoperidone in the rat and rabbit,” Toxicology, vol. 8, no. 1, pp. 87–94, 1977. View at Scopus
  12. A. W. Hayes, Principles and Method of Toxicology, Reven Press, New York, NY, USA, 2nd edition, 1988.
  13. R. A. B. Drury and E. A. Wallington, Carleton's Histological Technique, Oxford University Press, London, UK, 5th edition, 1980.
  14. P. M. Vancutsem, J. G. Babish, and W. S. Schwark, “The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity,” The Cornell Veterinarian, vol. 80, no. 2, pp. 173–186, 1990. View at Scopus
  15. H. Tuchmann, Drug Effects on Fetus, ADIS Press, New York, NY, USA, 1975.
  16. M. Kurebe, H. Asaoka, and M. Moriguchi, “Toxicological studies on a new cephamycin, MT-141. IX. Its teratogenicity test in rats and rabbits,” Japanese Journal of Antibiotics, vol. 37, no. 6, pp. 1186–1210, 1984. View at Scopus
  17. M. A. Siddiqui and S. N. H. Naqvi, “Evaluation of the teratogenic potentials of ciprofloxacin in albino rat,” Journal of Morphological Sciences, vol. 27, no. 1, pp. 14–18, 2010. View at Scopus
  18. S. Takayama, T. Watanabe, and Y. Akiyama, “Reproductive toxicity of ofloxacin,” Arzneimittel-Forschung, vol. 36, no. 8, pp. 1244–1248, 1986. View at Scopus
  19. T. Watanabe, K. Fujikawa, S. Harada, K. Ohura, T. Sasaki, and S. Takayama, “Reproductive toxicity of the new quinolone antibacterial agent levofloxacin in rats and rabbits,” Arzneimittel-Forschung A, vol. 42, no. 3, pp. 374–377, 1992. View at Scopus
  20. L. R. Zhang, Y. M. Wang, B. Y. Chen, and N. N. Cheng, “Neurotoxicity and toxicokinetics of norfloxacin in conscious rats,” Acta Pharmacologica Sinica, vol. 24, no. 6, pp. 605–623, 2003. View at Scopus
  21. K. Akahane, M. Kato, and S. Takayama, “Involvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in mice,” Antimicrobial Agents and Chemotherapy, vol. 37, no. 9, pp. 1764–1770, 1993. View at Scopus
  22. P. Hussy, G. Maass, and B. Tummler, “Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase α primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts,” Antimicrobial Agents and Chemotherapy, vol. 29, no. 6, pp. 1073–1078, 1986. View at Scopus
  23. S. H. Elsea, P. R. McGuirk, T. D. Gootz, M. Moynihan, and N. Osheroff, “Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential,” Antimicrobial Agents and Chemotherapy, vol. 37, no. 10, pp. 2179–2186, 1993. View at Scopus
  24. R. Stahlmann, “Clinical toxicological aspects of fluoroquinolones,” Toxicology Letters, vol. 127, no. 1–3, pp. 269–277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Kang, L. Wang, X. Chen, D. J. Triggle, and D. Rampe, “Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG,” Molecular Pharmacology, vol. 59, no. 1, pp. 122–126, 2001. View at Scopus
  26. E. C. Gilfillan, B. A. Pelak, and J. A. Bland, “Pharmacokinetic studies of norfloxacin in laboratory animals,” Chemotherapy, vol. 30, no. 5, pp. 288–296, 1984. View at Scopus
  27. G. J. Davis and B. E. McKenzie, “Toxicologic evaluation of ofloxacin,” American Journal of Medicine C, vol. 87, supplement 6, pp. 43S–46S, 1989. View at Scopus
  28. J. C. Kim, D.-H. Shin, S.-H. Kim et al., “Peri- and postnatal developmental toxicity of the fluoroquinolone antibacterial DW-116 in rats,” Food and Chemical Toxicology, vol. 42, no. 3, pp. 389–395, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. C. Kim, S. H. Kim, D. H. Shin et al., “Developmental toxicity assessment of the new fluoroquinolone antibacterial DW-116 in rabbits,” Journal of Applied Toxicology, vol. 25, no. 1, pp. 52–59, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. M. Hall, J. T. Finnoff, and J. Smith, “Musculoskeletal complications of fluoroquinolones: guidelines and precautions for usage in the athletic population,” Journal of Injury, Function and Rehabilitation, vol. 3, no. 2, pp. 132–142, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Stahlmann, “Children as a special population at risk-quinolones as an example for xenobiotics exhibiting skeletal toxicity,” Archives of Toxicology, vol. 77, no. 1, pp. 7–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. N. K. Arora, “Are fluoroquinolones safe in children?” Indian Journal of Pediatrics, vol. 61, no. 6, pp. 601–603, 1994. View at Scopus
  33. C. W. Jeffry, S. K. Soo, D. R. James et al., “Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors,” Journal of Medicinal Chemistry, vol. 43, no. 10, pp. 2019–2030, 2000. View at Publisher · View at Google Scholar · View at Scopus